Nephros Inc (NEPH)

Currency in USD
3.640
-0.130(-3.45%)
Closed·
3.476-0.164(-4.51%)
·
NEPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.4013.850
52 wk Range
2.6636.420
Key Statistics
Prev. Close
3.77
Open
3.85
Day's Range
3.401-3.85
52 wk Range
2.663-6.42
Volume
7.43K
Average Volume (3m)
19.2K
1-Year Change
1.9608%
Book Value / Share
1.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.000
Upside
+64.84%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Nephros Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.000
(+64.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Northland
Hold4.00+9.89%-New CoverageJul 17, 2026
Benchmark
Buy6.00+64.84%6.00MaintainMar 18, 2026
Benchmark
Buy5.00+37.36%5.00MaintainAug 12, 2025
Maxim Group
Buy6.00+64.84%4.50MaintainAug 08, 2025

Nephros Inc Earnings Call Summary for Q1/2026

  • Nephros Q1 2026 revenue hit record $5.2M (up 7% YoY), beating forecast of $5.14M; EPS met expectations at $0.01; stock rose 2.48% to $3.30
  • Gross margin compressed to 57% from 65% due to tariffs and FX headwinds; net income plunged 75% YoY to $140K; adjusted EBITDA fell 69% to $206K
  • Company expanding strategically into commercial water applications (ice machines, fountains) beyond healthcare to access larger addressable markets
  • Programmatic revenue surged 23% YoY offsetting emergency response decline; full-year 2026 revenue guidance set at $20.47M, rising to $22.86M in 2027
  • Management forecasts Q3/Q4 2026 EPS of $0.02/$0.03 respectively; analysts bullish with $6-$8 price targets implying 100%+ upside from current levels
Last Updated: 05/08/2026, 09:02 AM
Read Full Transcript

Earnings

Latest Release
Jul 22, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
5M / 5.05M
EPS Revisions
Last 90 days

NEPH Income Statement

Compare NEPH to Peers and Sector

Metrics to compare
NEPH
Peers
Sector
Relationship
P/E Ratio
50.9x42.7x12.3x
PEG Ratio
−7.880.460.03
Price/Book
3.7x3.4x1.4x
Price / LTM Sales
2.1x1.4x1.2x
Upside (Analyst Target)
64.8%34.7%28.6%
Fair Value Upside
Unlock14.4%8.6%Unlock

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
333.24K3.07%1.21M
Other Institutional Investors
5.58M51.36%20.30M
Public Companies & Retail Investors
4.95M45.57%18.01M
Total
10.86M100.00%39.52M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Wexford Capital LP33.16%3,600,55213,106
Topline Capital Partners, LP5.48%595,3342,167

People Also Watch

241.79
MOD
-3.14%
30.33
PLAB
-1.97%
15.090
MRAM
-9.10%
13.44
FLNC
-6.80%
104.04
FORM
-7.73%

FAQ

What Is the Nephros (NEPH) Stock Price Today?

The Nephros stock price today is 3.640 USD.

What Stock Exchange Does Nephros Trade On?

Nephros is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nephros?

The stock symbol for Nephros is "NEPH."

What Is the Nephros Market Cap?

As of today, Nephros market cap is 39.520M USD.

What Is Nephros's Earnings Per Share (TTM)?

The Nephros EPS (TTM) is 0.071.

When Is the Next Nephros Earnings Date?

Nephros will release its next earnings report on Nov 05, 2026.

From a Technical Analysis Perspective, Is NEPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nephros Stock Split?

Nephros has split 2 times.

How Many Employees Does Nephros Have?

Nephros has 36 employees.

What is the current trading status of Nephros (NEPH)?

As of Jul 26, 2026, Nephros (NEPH) is trading at a price of 3.640 USD, with a previous close of 3.770 USD. The stock has fluctuated within a day range of 3.401 USD to 3.850 USD, while its 52-week range spans from 2.663 USD to 6.420 USD.

What Is Nephros (NEPH) Price Target According to Analysts?

The average 12-month price target for Nephros is 6.000 USD, with a high estimate of 8 USD and a low estimate of 4 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +64.84% Upside potential.

What Is the NEPH After Hours Price?

NEPH's last after hours stock price is 3.476 USD, the stock has decreased by -0.164, or -4.510%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.